The medicolegal framework for driving and disease is one of the most important yet least well-understood aspects of GP practice — the DVLA Assessing Fitness to Drive guide (published annually at GOV.UK) contains approximately 180 medical conditions and their specific driving restrictions. GPs have three specific duties: (1) to advise patients when a medical condition or treatment affects their fitness to drive; (2) to document that this advice was given; and (3) in exceptional circumstances where a patient continues to drive despite advice to stop and poses a clear risk to the public, to report to the DVLA directly (after warning the patient of the intention to do so). The Patient Confidentiality Act does not prevent disclosure to the DVLA when there is a serious safety concern — the GMC guidance 'Confidentiality: patients' fitness to drive and reporting concerns to the DVLA/DVA' (2017) specifically permits disclosure without patient consent if: the patient does not inform the DVLA despite repeated advice, and continued driving would pose a significant safety risk. The documentation standard: at every consultation where a driving-relevant condition is identified, diagnosed, or deteriorates: record 'patient advised re: DVLA notification requirement for [condition] + driving restrictions — patient acknowledges and will notify/stop driving.' This takes one line and is legally protective.

The taxi licensing complexity is frequently overlooked in primary care — local authority licensing of taxis does not fall under DVLA Group 2 rules (some local authorities require Group 2 standards, others Group 1) but GPs are sometimes asked to provide medical reports for taxi licence applications. The GP's role in these reports is factual — state the condition, its current treatment, and its stability. GPs should not determine whether the applicant is 'fit to drive a taxi' — that determination is made by the licensing authority. GPs should also be aware that some conditions have specific DVLA rules that differ between Group 1 and Group 2 in ways that can surprise patients: for example, a controlled epileptic who has been seizure-free for 12 months can hold a Group 1 licence but cannot hold a Group 2 licence for 10 years. A patient who changes jobs to HGV driving while on antiepileptic medication may not realise this until they attempt to upgrade their licence.

The insulin-treated diabetes driving rules are comprehensive and clinically important — the DVLA updated these rules in 2019 with more permissive standards for Group 1 licence holders: (1) Check blood glucose ≥5.0 mmol/L within 2 hours before driving. (2) Stop driving if glucose <5.0 mmol/L — treat with fast-acting glucose, wait until 45 minutes after glucose has risen above 5.0 mmol/L before resuming driving. (3) Carry fast-acting glucose in the vehicle at all times (glucose tablets, GlucoJuice). (4) If hypoglycaemia occurs while driving: pull over safely, stop the engine, move to passenger seat, treat hypoglycaemia, wait 45 minutes, and recheck glucose before driving. (5) Use CGM (continuous glucose monitoring) if available — but CGM alone is not sufficient to replace blood glucose checking before driving in the UK (CGM values can lag 15 minutes behind blood glucose). The '2 severe hypos in 12 months' rule: any patient with IDDM who has had ≥2 episodes requiring third-party assistance to treat (i.e., the patient could not self-treat) in the past 12 months must notify DVLA and cannot drive Group 1 until: hypo unawareness is addressed, treatment is reviewed by a diabetes specialist, and 3 months of pre-driving glucose checking is demonstrated.

OSA-related road accidents are responsible for approximately 20% of all HGV road traffic fatalities in the UK — making OSA screening and treatment one of the most important public safety interventions in primary care. The Epworth Sleepiness Scale (ESS) is a validated 8-question self-reported tool that GPs can administer in 2 minutes — a score above 10 indicates excessive daytime sleepiness warranting investigation. Any patient with EDS should be asked explicitly about driving: 'Do you drive for work? Have you ever felt sleepy at the wheel or had a near-miss?' A positive answer to these questions in the context of ESS >10 should prompt urgent sleep medicine referral AND an explicit conversation about ceasing driving until the condition is assessed and treated. The DVLA rules: diagnosed OSA with EDS = must notify DVLA and must not drive Group 2 until CPAP compliance is confirmed and EDS is resolved. For Group 1: notify DVLA if driving is impaired; can resume driving when EDS is controlled with CPAP. CPAP treatment is highly effective — most patients have complete resolution of EDS within 2–4 weeks of consistent use.

NHS driving assessment centres (DACs) provide expert on-road assessment for patients with conditions that may affect driving ability — they are staffed by occupational therapists with specialist driving assessment training and driving instructors. They can assess: whether a patient with dementia, stroke, severe physical disability, or brain injury can safely continue driving, what adaptations (hand controls, wider mirrors, automatic transmission) might enable safe driving, and provide a formal report to the DVLA and the GP. There are approximately 30 NHS DACs across the UK (listed on the Forum of Mobility Centres website). GP referral to a DAC is appropriate for: patients who want to continue driving after a neurological event or diagnosis, where clinical assessment alone is insufficient to determine fitness, and where the patient or family disputes the GP's assessment of driving fitness. The DAC report provides objective evidence to support or refute the patient's ability to drive safely, and significantly reduces the medico-legal burden on GPs in complex cases.

The insurance invalidation consequence is often the most persuasive argument for a reluctant patient to notify the DVLA and comply with driving restrictions — patients who resist stopping driving on safety grounds may change their view when they understand that: any accident while driving with an undeclared condition invalidates their motor insurance, meaning they would be personally liable for third-party damages (which could be hundreds of thousands of pounds in a serious accident), their licence could be revoked, and they could face criminal prosecution. This is a factual legal statement, not a threat — GPs can use it constructively: 'I understand this is very difficult, but I want to make sure you understand the full picture. If you were involved in an accident while driving with this condition undeclared, your insurance would not cover you. You would be personally responsible for any damages.' This approach respects patient autonomy while ensuring fully informed decision-making.

The CAA vs DVLA distinction is clinically important because patients who are pilots often do not spontaneously declare this when discussing a new medical condition — they may not realise the implications for their licence, or may be reluctant to acknowledge the implications. GPs should proactively ask 'Do you hold any aviation licence or work in aviation?' at the first consultation for any potentially aviation-relevant condition (cardiac, neurological, psychiatric, vision). The CAA standards are in many cases stricter than DVLA standards: for example, a single episode of AF may not affect DVLA Group 1 driving after treatment, but would require CAA review and potentially a period off flying with serial cardiac assessments before return to aviation. GPs who advise a pilot patient about driving fitness using DVLA rules without mentioning CAA may be giving incomplete advice — the patient may comply with DVLA requirements and continue flying without understanding that separate CAA notification is needed.

The GP form completion fee for DVLA medical reports (D4/D952) is an allowable charge — completing DVLA medical forms is not part of the NHS contract for GP services and GPs are entitled to charge a fee (BMA suggested fee: approximately £200–250 for a D4 report in 2024). The GP should explain this to patients before agreeing to complete the form — patients need to understand that they will be charged, and the fee must be agreed before the consultation. GPs who routinely complete these forms should have a practice policy on fees, a standard process for reviewing relevant clinical history and specialist letters, and a turnaround time communicated to patients. Accuracy is paramount — a GP who provides inaccurate information on a DVLA medical form (whether overstating or understating the patient's condition) faces both regulatory risk (GMC fitness to practise) and civil liability. When in doubt about a clinical finding's relevance to fitness to drive, GPs should contact the DVLA's medical advisory branch (0300 790 6806) for guidance before completing the form.

The GMC guidance on confidentiality and DVLA reporting (updated 2017) provides the ethical framework that governs GP decision-making when a patient refuses to comply with driving restrictions — it represents one of the few situations where a GP may ethically breach patient confidentiality without consent. The key conditions that must all be met before a GP can report to DVLA without patient consent: (1) the condition poses a serious risk of harm to the patient or others if driving continues; (2) the GP has given the patient the opportunity to inform the DVLA themselves and the patient has refused; (3) disclosure is necessary and proportionate to prevent the risk; and (4) the GP has warned the patient that disclosure will be made. In practice, the threshold for direct GP reporting is high — it should be reserved for cases where the clinical risk is serious (not merely theoretical) and the patient is actively continuing to drive despite clear advice. For most cases, thorough documentation of advice given is sufficient — if an accident occurs and the GP has documented clear and repeated advice, the legal and professional protection is substantially stronger.